Includes bibliographical references and index.
|Other titles||Hansten and Horn managing clinically important drug interactions|
|Statement||Philip D. Hansten, John R. Horn.|
|Genre||Handbooks, manuals, etc.|
|Contributions||Horn, John R.|
|LC Classifications||RM302 .H365 2002|
|The Physical Object|
|Pagination||xiii, 647 p. ;|
|Number of Pages||647|
|LC Control Number||98072864|
Get this from a library! Managing clinically important drug interactions. [Philip D Hansten; John R Horn] -- "Containing drug interaction information extracted from Hansten and Horn's Drug Interactions Analysis and Management, this new bound edition offers information you need in a handy, portable format. Medical Book Hansten and Horn Managing Clinically Important Drug Interactions Only level 1 and 2 interactions and those level 3 interactions most likely to affect patient outcomes are included. The information is compiled from up-to-date biomedical studies and case reports and presented in a quick-reference format. This title provides brief descriptions of clinically important drug interactions selected from the authoritative looseleaf reference, "Drug Interactions Analysis and Management". Only level 1 and 2 interactions and those level 3 interactions most likely to affect patient outcomes are included. Find many great new & used options and get the best deals for Hansten and Horn's Managing Clinically Important Drug Interactions by John R. Horn and Philip D. Hansten (, Book, Other) at the best online prices at eBay! Free shipping for many products!
Managing Clinically Important Drug Interactions is a bound version of Drug Interactions Analysis and Management. It is condensed to include those monographs that contain level 1 and 2 drug-drug and drug-food interactions along with those level 3 Author: Philip D. Hansten. This handy book provides brief descriptions of clinically important drug interactions selected from the authoritative looseleaf reference, Drug Interactions Analysis and Management. Only level 1 and 2 interactions and those level 3 interactions most likely to affect patient outcomes are : Philip D. Hansten, John R. Horn. Herb–drug interactions Warfarin Shengmaiyin (Promoting the Pulse Drink) is a popular Chinese herbal product, which contains Ginseng radix et rhizoma rubra (Hongshen), Ophiopogonis radix (Maidong), and Schisandrae chinensis fructus (Wuweizi). Shengmaiyin is commonly used for cardiovascular and cerebrovascular diseases and oxidative damage in other organs [13 c, 14 . "Hansten and Horn's Drug Interactions Analysis and Management" assists in the prevention and management of drug interactions, achieving improved patient outcomes. Each interaction monograph includes a ranking system clearly indicating the level of patient risk. Noninteractions are also included. Each monograph contains a summary, risk factors.
The Paperback of the Hansten and Horn's Managing Clinically Important Drug Interactions by Hansten, John R. Horn | at Barnes & Noble. FREE Shipping on B&N Outlet Membership Educators Gift Cards Stores & Events HelpAuthor: Hansten. The prescribing information for most drugs contains a list of potential drug interactions. Many of the listed interactions may be rare, minor, or only occur under specific conditions and may not be important. Drug interactions that cause important changes in the action of a drug are of the greatest concern. Drug interactions should be considered as a possible cause of any unexpected problems. When unexpected clinical responses occur, prescribers should determine serum concentrations of selected drugs being taken, consult the literature or an expert in drug interactions, and adjust the dosage until the desired effect is produced. • A book called “Drug Interactions” went to press 35yrs ago and contained a few hundred drug interactions – Today, the book is called “Drug Interactions Analysis and Management” and contains thousands of interactions Hansten and Horn’s Drug Interactions Analysis and Management, Wolters Kluwer Health, Inc File Size: KB.